Purpose: To assess the impact of concomitant use of perfluorohexyloctane ophthalmic solution (PFHO) during contact lens wear.
Methods: In this phase 4, multicenter, prospective, open-label study, habitual wearers of soft, frequent-replacement contact lenses instilled PFHO bilaterally 4 times daily (1 time before, 3 times while wearing lenses) for 30 days. The primary outcome measure was the Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8; maximum score: 37).
Results: In 104 enrolled patients (female, 79.8%; age range, 18–67 years), mean (SD) CLDEQ-8 score at baseline was 12.2 (6.6). Mean (SD) change from baseline was −2.8 (4.9) at Day 7, −3.8 (4.7) at Day 14, and −4.3 (5.8) at Day 30 (P<0.001). Total daily contact lens wear time, comfortable wear time, and end-of-day eye dryness were also significantly improved (P<0.001). No serious adverse events were reported; 1 patient (1.0%) discontinued PFHO due to adverse events (eye dryness, instillation discomfort).
Conclusion: PFHO use was well tolerated in contact lens wearers and was associated with improvements in patient-reported assessments of contact lens performance and tolerability.